Showing results (251-260 of 279) with videos related to
Sort By:
Pageof 28
Lupus|April 17, 2007
Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptomsI Avalos, C P Chung, A Oeser, et al.The Journal of Rheumatology|December 1, 1992
Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugsT Pincus, S B Marcum, L F Callahan, et al.Hypertension (Dallas, Tex. : 1979)|October 6, 1997
Sympathoinhibitory response to clonidine is blunted in patients with heart failureC C Lang, C M Stein, R A Nelson, et al.Lupus|February 20, 2020
Tissue sodium content in patients with systemic lupus erythematosus: association with disease activity and markers of inflammationD A Carranza-León, A Oeser, A Marton, et al.Molecular Pharmacology|July 17, 2001
Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African AmericansL J Dickmann, A E Rettie, M B Kneller, et al.Journal of Environmental Quality|February 10, 2009
Effects of mechanical harvest plus chipping and prescribed fire on Sierran runoff water qualityT M Loupe, W W Miller, D W Johnson, et al.The Journal of Rheumatology|February 11, 1999
Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatologyF Wolfe, M Lassere, D van der Heijde, et al.The Pharmacogenomics Journal|April 20, 2016
Genetic variation in the alpha1B-adrenergic receptor and vascular responseA Adefurin, L V Ghimire, U Kohli, et al.Pharmacogenetics|May 8, 2001
Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivoH G Xie, V Dishy, G Sofowora, et al.Pharmacogenetics|December 12, 2001
In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphismG Sofowora, V Dishy, H G Xie, et al.Pageof 28